These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22306851)

  • 1. Changes in blood pressure and systemic vascular resistance do not predict microvascular structure during treatment of mild essential hypertension.
    Eftekhari A; Mathiassen ON; Buus NH; Gotzsche O; Mulvany MJ; Christensen KL
    J Hypertens; 2012 Apr; 30(4):794-801. PubMed ID: 22306851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive effects of aggressive vasodilator treatment of well-treated essential hypertensive patients.
    Engholm M; Mulvany MJ; Eftekhari A; Mathiassen ON; Buus NH; Christensen KL
    J Hum Hypertens; 2016 Nov; 30(11):690-696. PubMed ID: 26961172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disproportionally impaired microvascular structure in essential hypertension.
    Eftekhari A; Mathiassen ON; Buus NH; Gotzsche O; Mulvany MJ; Christensen KL
    J Hypertens; 2011 May; 29(5):896-905. PubMed ID: 21330935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small artery structure adapts to vasodilatation rather than to blood pressure during antihypertensive treatment.
    Mathiassen ON; Buus NH; Larsen ML; Mulvany MJ; Christensen KL
    J Hypertens; 2007 May; 25(5):1027-34. PubMed ID: 17414667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial and forearm blood flow reserve in mild-moderate essential hypertensive patients.
    Pedrinelli R; Dell'Omo G; Gimelli A; Di Bello V; Talarico L; Corchia A; Sambuceti G; Neglia D; Parodi O
    J Hypertens; 1997 Jun; 15(6):667-73. PubMed ID: 9218187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renal denervation on coronary flow reserve and forearm dilation capacity in patients with treatment-resistant hypertension. A randomized, double-blinded, sham-controlled clinical trial.
    Engholm M; Bertelsen JB; Mathiassen ON; Bøtker HE; Vase H; Peters CD; Bech JN; Buus NH; Schroeder AP; Rickers H; Hansen KW; Poulsen PL; Kaltoft A; Christensen KL
    Int J Cardiol; 2018 Jan; 250():29-34. PubMed ID: 29042091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forearm plethysmography in the assessment of vascular tone and resistance vasculature design: new methodological insights.
    Mathiassen ON; Buus NH; Olsen HW; Larsen ML; Mulvany MJ; Christensen KL
    Acta Physiol (Oxf); 2006 Oct; 188(2):91-101. PubMed ID: 16948796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of pulse wave velocity on coronary flow reserve in patients with essential hypertension].
    Wang GH; Hu DY
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):54-7. PubMed ID: 15808080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy.
    Dahlöf B
    Blood Press Suppl; 1992; 6():1-75. PubMed ID: 1345261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between carotid wall thickness and forearm blood flow reserve in hypertension.
    Pedrinelli R; Dell'Omo G; Catapano G; Talarico L; Di Bello V; Petrucci R; Napoli V
    Coron Artery Dis; 1995 Nov; 6(11):845-50. PubMed ID: 8696528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of blood pressure and resistance artery structure: potential clinical implications.
    Christensen KL; Buus NH
    Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):73-9. PubMed ID: 21920026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of an antihypertensive diuretic substance on the forearm circulation of patients with essential hypertension.
    Bouthier JA; Safar ME; Deschamps E; Tarrade T
    Drugs Exp Clin Res; 1988; 14(2-3):221-4. PubMed ID: 3416724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure.
    Hashimoto J; Imai Y; O'Rourke MF
    Am J Hypertens; 2007 Apr; 20(4):378-84. PubMed ID: 17386343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy.
    Olsen MH; Christensen MK; Wachtell K; Tuxen C; Fossum E; Bang LE; Wiinberg N; Devereux RB; Kjeldsen SE; Hildebrandt P; Dige-Petersen H; Rokkedal J; Ibsen H
    J Hum Hypertens; 2005 Apr; 19(4):301-7. PubMed ID: 15647776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension.
    Porcellati C; Verdecchia P; Schillaci G; Boldrini F; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):187-97. PubMed ID: 1830037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Castellano M; Cavaliere G; Nordio G; Pasini F; Zuccato F
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S37-43. PubMed ID: 7603076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.